MEMANTINE HYDROCHLORIDE

MEMANTINE HYDROCHLORIDE was reported 2808 times

MEMANTINE HYDROCHLORIDE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 MIXED DEMENTIA 9 0.1406
1 SPUR CELL ANAEMIA 9 0.1343
2 BODY TINEA 56 0.1000
3 ECHOLALIA 31 0.0975
4 POST-TRAUMATIC HEADACHE 12 0.0764
5 TRIFASCICULAR BLOCK 8 0.0734
6 SUPERFICIAL SIDEROSIS OF CENTRAL NERVOUS SYSTEM 9 0.0709
7 EOSINOPHILIC PLEURAL EFFUSION 19 0.0638
8 AMYLOID RELATED IMAGING ABNORMALITY-MICROHAEMORRHAGES AND HAEMOSIDERIN DEPOSITS 63 0.0587
9 PLEUROTHOTONUS 47 0.0520
10 BIFASCICULAR BLOCK 9 0.0481
11 MYOCARDIAL OEDEMA 19 0.0481
12 CENTRAL PAIN SYNDROME 11 0.0415
13 INHIBITORY DRUG INTERACTION 53 0.0335
14 DEMENTIA WITH LEWY BODIES 37 0.0332
15 THERAPEUTIC DRUG MONITORING ANALYSIS NOT PERFORMED 9 0.0305
16 FRONTOTEMPORAL DEMENTIA 12 0.0280
17 NEUROPSYCHOLOGICAL SYMPTOMS 16 0.0265
18 INFECTION SUSCEPTIBILITY INCREASED 56 0.0256
19 ELECTROCARDIOGRAM PR PROLONGATION 18 0.0235
20 RHYTHM IDIOVENTRICULAR 7 0.0215
21 LACK OF SPONTANEOUS SPEECH 9 0.0205
22 POVERTY OF SPEECH 8 0.0204
23 OESOPHAGEAL DILATATION 9 0.0204
24 SIALOADENITIS 27 0.0198
25 PATIENT ELOPEMENT 7 0.0191
26 DROPPED HEAD SYNDROME 7 0.0177
27 INTESTINAL PSEUDO-OBSTRUCTION 15 0.0171
28 SEXUALLY INAPPROPRIATE BEHAVIOUR 7 0.0150
29 REPETITIVE SPEECH 8 0.0142
30 PRODUCT INEFFECTIVE 11 0.0140
31 HYPORESPONSIVE TO STIMULI 16 0.0136
32 CHOREA 23 0.0133
33 BILIARY SEPSIS 6 0.0130
34 PARKINSONIAN GAIT 8 0.0128
35 DEMENTIA 349 0.0125
36 ANAEMIA NEONATAL 6 0.0124
37 THOUGHT BLOCKING 7 0.0119
38 HYPERGLYCAEMIC HYPEROSMOLAR NONKETOTIC SYNDROME 13 0.0117
39 MOANING 13 0.0114
40 CATATONIA 60 0.0114
41 EXCESSIVE CERUMEN PRODUCTION 7 0.0113
42 STOMA SITE HYPERGRANULATION 7 0.0111
43 BRADYARRHYTHMIA 18 0.0109
44 HALLUCINATIONS, MIXED 46 0.0109
45 DIET REFUSAL 8 0.0109
46 ILLUSION 18 0.0109
47 DELUSION 169 0.0109
48 ATRIOVENTRICULAR BLOCK FIRST DEGREE 47 0.0108
49 HYPERNATRAEMIA 52 0.0104
50 GLUCOSE TOLERANCE IMPAIRED 59 0.0100
51 STEREOTYPY 9 0.0095
52 APTYALISM 8 0.0094
53 NONSPECIFIC REACTION 51 0.0093
54 AKINESIA 19 0.0092
55 VASCULAR DEMENTIA 8 0.0091
56 STOMA SITE HAEMORRHAGE 14 0.0091
57 INTENTIONAL MEDICAL DEVICE REMOVAL BY PATIENT 9 0.0089
58 MYOCLONUS 106 0.0089
59 HALLUCINATION, VISUAL 187 0.0088
60 HALLUCINATION 653 0.0087
61 POSTURE ABNORMAL 28 0.0086
62 STOMA SITE DISCHARGE 23 0.0084
63 DEMENTIA ALZHEIMER'S TYPE 14 0.0084
64 APALLIC SYNDROME 6 0.0083
65 ATRIOVENTRICULAR BLOCK SECOND DEGREE 25 0.0082
66 SEDATION COMPLICATION 21 0.0082
67 IMMUNE THROMBOCYTOPENIA 37 0.0081
68 STOMA SITE ERYTHEMA 15 0.0080
69 NEUROPSYCHIATRIC SYMPTOMS 7 0.0078
70 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 78 0.0076
71 FREEZING PHENOMENON 27 0.0073
72 DEVICE ALARM ISSUE 13 0.0072
73 FACIAL SPASM 8 0.0071
74 CONDUCTION DISORDER 13 0.0071
75 SKIN OEDEMA 7 0.0070
76 FOAMING AT MOUTH 14 0.0069
77 DELIRIUM 240 0.0069
78 PURPURA 60 0.0068
79 COGWHEEL RIGIDITY 7 0.0067
80 ORTHOSTATIC HYPOTENSION 115 0.0066
81 APPLICATION SITE HYPERSENSITIVITY 8 0.0066
82 MARASMUS 10 0.0066
83 ABULIA 6 0.0065
84 SLEEP TALKING 11 0.0065
85 SEIZURE LIKE PHENOMENA 11 0.0065
86 NEUROLEPTIC MALIGNANT SYNDROME 75 0.0063
87 ANXIETY DISORDER 21 0.0063
88 STARING 15 0.0062
89 BEHAVIOUR DISORDER 33 0.0061
90 ANAEMIA MACROCYTIC 13 0.0061
91 PERSECUTORY DELUSION 15 0.0060
92 BRADYKINESIA 34 0.0058
93 EMOTIONAL POVERTY 10 0.0057
94 CRYPTOCOCCOSIS 9 0.0055
95 CEREBRAL ATROPHY 22 0.0055
96 MUTISM 8 0.0055
97 ARRHYTHMIA SUPRAVENTRICULAR 6 0.0055
98 PETIT MAL EPILEPSY 28 0.0055
99 FEMORAL NECK FRACTURE 28 0.0055
100 BRADYCARDIA 287 0.0054
101 PNEUMONIA ASPIRATION 135 0.0054
102 FAILURE TO THRIVE 28 0.0054
103 STOMA SITE INFECTION 7 0.0054
104 METASTATIC NEOPLASM 23 0.0053
105 PSYCHOTIC SYMPTOM 11 0.0053
106 GAZE PALSY 9 0.0053
107 ON AND OFF PHENOMENON 29 0.0052
108 ACCIDENTAL POISONING 7 0.0051
109 SINUS BRADYCARDIA 49 0.0051
110 IMMOBILE 22 0.0050
111 AGITATION 369 0.0050
112 HYPERLIPIDAEMIA 60 0.0050
113 NOSOCOMIAL INFECTION 11 0.0050
114 LOW DENSITY LIPOPROTEIN DECREASED 7 0.0049
115 IMPAIRED QUALITY OF LIFE 71 0.0049
116 PARKINSONISM 48 0.0049
117 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 13 0.0049
118 DISORGANISED SPEECH 9 0.0049
119 ABNORMAL BEHAVIOUR 191 0.0048
120 HOSPICE CARE 47 0.0048
121 CONFUSIONAL STATE 763 0.0047
122 AGGRESSION 233 0.0047
123 DROOLING 32 0.0046
124 BLOOD CHLORIDE INCREASED 8 0.0046
125 SOPOR 61 0.0046
126 MUSCLE RIGIDITY 55 0.0046
127 HYPOXIC-ISCHAEMIC ENCEPHALOPATHY 12 0.0046
128 SLOW SPEECH 11 0.0045
129 ATRIOVENTRICULAR BLOCK 35 0.0045
130 POOR QUALITY SLEEP 97 0.0045
131 SEROTONIN SYNDROME 86 0.0045
132 COMMUNICATION DISORDER 17 0.0044
133 HYPOTHERMIA 45 0.0044
134 DECUBITUS ULCER 36 0.0044
135 METASTASES TO MENINGES 10 0.0044
136 PSYCHOMOTOR HYPERACTIVITY 72 0.0043
137 METABOLIC ENCEPHALOPATHY 13 0.0043
138 HYPERREFLEXIA 15 0.0043
139 MENTAL STATUS CHANGES 119 0.0043
140 ELECTROCARDIOGRAM QT PROLONGED 153 0.0042
141 FLUID INTAKE REDUCED 21 0.0042
142 INCOHERENT 27 0.0042
143 LANGUAGE DISORDER 9 0.0042
144 HYPOPHAGIA 106 0.0041
145 REHABILITATION THERAPY 16 0.0041
146 COGNITIVE DISORDER 192 0.0041
147 CERVICAL SPINAL STENOSIS 7 0.0041
148 APRAXIA 6 0.0040
149 HALLUCINATION, AUDITORY 64 0.0040
150 SALIVARY HYPERSECRETION 40 0.0040
151 MUSCLE CONTRACTURE 8 0.0039
152 LUNG CONSOLIDATION 11 0.0039
153 ENCEPHALOPATHY 95 0.0039
154 DYSKINESIA 156 0.0038
155 ESSENTIAL HYPERTENSION 7 0.0038
156 PNEUMONIA KLEBSIELLA 7 0.0038
157 VOLVULUS 9 0.0038
158 POLYDIPSIA 15 0.0038
159 TORTICOLLIS 8 0.0038
160 TOXIC ENCEPHALOPATHY 19 0.0037
161 ATRIOVENTRICULAR BLOCK COMPLETE 25 0.0037
162 STUPOR 12 0.0037
163 PRODUCT ADMINISTRATION INTERRUPTED 29 0.0037
164 INCONTINENCE 39 0.0037
165 DISORIENTATION 146 0.0037
166 CLONUS 10 0.0037
167 CRANIOCEREBRAL INJURY 11 0.0036
168 ILEUS PARALYTIC 16 0.0036
169 APHASIA 108 0.0036
170 ANGLE CLOSURE GLAUCOMA 9 0.0035
171 BUNDLE BRANCH BLOCK RIGHT 16 0.0035
172 PERSONALITY CHANGE 32 0.0034
173 SEDATION 90 0.0034
174 HYPERTENSIVE CRISIS 38 0.0034
175 METASTASES TO CENTRAL NERVOUS SYSTEM 44 0.0034
176 LOGORRHOEA 12 0.0034
177 MANIA 56 0.0034
178 IMPAIRED SELF-CARE 7 0.0034
179 LACUNAR INFARCTION 8 0.0033
180 SCREAMING 21 0.0033
181 HYPERPHAGIA 13 0.0033
182 UNRESPONSIVE TO STIMULI 83 0.0032
183 HYPERSOMNIA 92 0.0032
184 SUSPECTED SUICIDE 15 0.0032
185 ORAL HERPES 62 0.0032
186 URINARY INCONTINENCE 94 0.0032
187 WHEELCHAIR USER 14 0.0031
188 HIP FRACTURE 101 0.0031
189 ATAXIA 37 0.0031
190 COMA SCALE ABNORMAL 9 0.0031
191 GASTROINTESTINAL HYPOMOTILITY 7 0.0031
192 FAECALOMA 17 0.0031
193 FALL 1030 0.0031
194 HAEMATOCRIT INCREASED 7 0.0031
195 PEMPHIGOID 23 0.0030
196 EXFOLIATIVE RASH 8 0.0030
197 PARANOIA 52 0.0030
198 DEPRESSED LEVEL OF CONSCIOUSNESS 119 0.0030
199 SKIN ABRASION 14 0.0030
200 IMPAIRED WORK ABILITY 63 0.0029
201 MOTOR DYSFUNCTION 30 0.0029
202 IMPULSIVE BEHAVIOUR 11 0.0029
203 HYPONATRAEMIA 161 0.0029
204 ASPIRATION 31 0.0028
205 HAEMORRHAGIC STROKE 22 0.0028
206 HYPOTONIA 28 0.0028
207 LUNG CANCER METASTATIC 8 0.0028
208 SPEECH DISORDER 144 0.0027
209 SUBDURAL HAEMATOMA 39 0.0027
210 CYTOLYTIC HEPATITIS 9 0.0027
211 ALTERED STATE OF CONSCIOUSNESS 58 0.0027
212 TORSADE DE POINTES 21 0.0027
213 PARTIAL SEIZURES 14 0.0027
214 URINARY TRACT INFECTION 454 0.0027
215 PROTEIN TOTAL DECREASED 10 0.0027
216 RESTLESSNESS 97 0.0026
217 BALANCE DISORDER 226 0.0026
218 IRON DEFICIENCY ANAEMIA 24 0.0026
219 BRADYPNOEA 7 0.0026
220 BRAIN INJURY 26 0.0026
221 WRONG PATIENT RECEIVED MEDICATION 7 0.0026
222 VITAMIN D DEFICIENCY 25 0.0026
223 ANAL INCONTINENCE 23 0.0026
224 PROSTATOMEGALY 10 0.0025
225 TERMINAL STATE 17 0.0025
226 RED BLOOD CELL COUNT INCREASED 7 0.0025
227 GENERALISED TONIC-CLONIC SEIZURE 42 0.0025
228 MALNUTRITION 28 0.0025
229 DEVICE KINK 9 0.0025
230 AUTONOMIC NERVOUS SYSTEM IMBALANCE 7 0.0024
231 LUMBAR SPINAL STENOSIS 7 0.0024
232 HEAD INJURY 75 0.0024
233 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED 12 0.0023
234 EYE MOVEMENT DISORDER 16 0.0023
235 SOMNOLENCE 469 0.0023
236 EPILEPSY 71 0.0023
237 HICCUPS 19 0.0023
238 REFUSAL OF TREATMENT BY PATIENT 15 0.0023
239 DYSSTASIA 67 0.0023
240 CEREBRAL HAEMORRHAGE 82 0.0023
241 PSYCHOTIC DISORDER 67 0.0023
242 PRESCRIBED UNDERDOSE 45 0.0023
243 DYSPHAGIA 213 0.0022
244 BRUXISM 12 0.0022
245 CELLULITIS 112 0.0022
246 PRODUCT USE COMPLAINT 35 0.0022
247 SKIN DISORDER 74 0.0022
248 SKIN LACERATION 24 0.0022
249 HYPOKINESIA 32 0.0022
250 MONOCYTE COUNT INCREASED 8 0.0022
251 AKATHISIA 30 0.0022
252 HYPERURICAEMIA 9 0.0022
253 CUSHINGOID 7 0.0022
254 PSYCHIATRIC SYMPTOM 16 0.0022
255 WOUND HAEMORRHAGE 8 0.0022
256 SUBARACHNOID HAEMORRHAGE 22 0.0022
257 ACCIDENTAL OVERDOSE 79 0.0022
258 MOBILITY DECREASED 154 0.0021
259 BRAIN OEDEMA 27 0.0021
260 DEVICE OCCLUSION 30 0.0021
261 BEDRIDDEN 28 0.0021
262 HYPERPYREXIA 9 0.0021
263 CARDIAC FAILURE CHRONIC 9 0.0021
264 COLITIS MICROSCOPIC 10 0.0021
265 SKIN INJURY 7 0.0021
266 TROPONIN INCREASED 16 0.0021
267 URINARY RETENTION 70 0.0021
268 SOCIAL AVOIDANT BEHAVIOUR 12 0.0021
269 DYSTONIA 40 0.0021
270 ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD 14 0.0021
271 SCHIZOPHRENIA 25 0.0021
272 ONYCHOMYCOSIS 9 0.0020
273 LETHARGY 118 0.0020
274 DRUG INTERACTION 324 0.0020
275 VENOUS THROMBOSIS 8 0.0020
276 GAIT INABILITY 68 0.0020
277 SYNCOPE 202 0.0020
278 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 110 0.0020
279 DEPRESSIVE SYMPTOM 7 0.0020
280 EXTRAPYRAMIDAL DISORDER 49 0.0020
281 LIVER FUNCTION TEST ABNORMAL 57 0.0020
282 DECREASED ACTIVITY 21 0.0019
283 RHABDOMYOLYSIS 81 0.0019
284 SEIZURE 224 0.0019
285 OLIGURIA 12 0.0019
286 PERFORMANCE STATUS DECREASED 9 0.0019
287 SPONDYLITIS 7 0.0019
288 INTERNATIONAL NORMALISED RATIO INCREASED 54 0.0019
289 GAIT DISTURBANCE 362 0.0019
290 HEMIPARESIS 32 0.0019
291 BONE DENSITY DECREASED 59 0.0019
292 CEREBRAL INFARCTION 46 0.0019
293 ESCHERICHIA URINARY TRACT INFECTION 8 0.0019
294 COORDINATION ABNORMAL 26 0.0019
295 PRESYNCOPE 45 0.0018
296 HIP SURGERY 10 0.0018
297 THERAPY NON-RESPONDER 83 0.0018
298 BRADYPHRENIA 12 0.0018
299 VENTRICULAR EXTRASYSTOLES 19 0.0018
300 CLAVICLE FRACTURE 7 0.0018
301 MEMORY IMPAIRMENT 251 0.0018
302 CONDITION AGGRAVATED 554 0.0018
303 DYSARTHRIA 68 0.0018
304 THERAPEUTIC PRODUCT EFFECT VARIABLE 7 0.0018
305 CARDIAC FAILURE ACUTE 12 0.0018
306 TREMOR 298 0.0018
307 DEHYDRATION 239 0.0018
308 COVID-19 PNEUMONIA 21 0.0018
309 WRONG PRODUCT ADMINISTERED 12 0.0018
310 LOSS OF CONSCIOUSNESS 225 0.0018
311 DRUG-INDUCED LIVER INJURY 55 0.0018
312 DRUG LEVEL INCREASED 29 0.0018
313 INFUSION SITE SWELLING 11 0.0017
314 DISEASE COMPLICATION 8 0.0017
315 DISTURBANCE IN ATTENTION 93 0.0017
316 DISSEMINATED INTRAVASCULAR COAGULATION 24 0.0017
317 SPINAL STENOSIS 7 0.0017
318 NYSTAGMUS 9 0.0017
319 MENTAL IMPAIRMENT 41 0.0017
320 MEDICATION ERROR 94 0.0017
321 PALLOR 46 0.0017
322 RESPIRATORY RATE INCREASED 15 0.0017
323 COMPRESSION FRACTURE 9 0.0017
324 APHTHOUS ULCER 13 0.0017
325 SLUGGISHNESS 17 0.0017
326 SLEEP TERROR 7 0.0017
327 CONTUSION 160 0.0017
328 INFUSION SITE ERYTHEMA 14 0.0017
329 HYDROCEPHALUS 9 0.0017
330 CONTRAINDICATED PRODUCT ADMINISTERED 50 0.0016
331 BLOOD SODIUM DECREASED 31 0.0016
332 HEAD DISCOMFORT 29 0.0016
333 PNEUMONIA BACTERIAL 15 0.0016
334 ATRIAL FLUTTER 13 0.0016
335 FEEDING DISORDER 33 0.0016
336 MIOSIS 13 0.0016
337 THERAPY PARTIAL RESPONDER 25 0.0016
338 LEUKOCYTOSIS 29 0.0016
339 ANGER 54 0.0016
340 SQUAMOUS CELL CARCINOMA 15 0.0016
341 PERIORBITAL SWELLING 9 0.0016
342 POLYURIA 13 0.0016
343 AORTIC ANEURYSM 12 0.0016
344 APATHY 23 0.0016
345 GASTRIC HAEMORRHAGE 18 0.0016
346 PHLEBITIS 8 0.0016
347 NIGHTMARE 54 0.0016
348 ATELECTASIS 15 0.0016
349 FEMUR FRACTURE 48 0.0015
350 TRANSIENT ISCHAEMIC ATTACK 52 0.0015
351 PERIORBITAL OEDEMA 8 0.0015
352 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 74 0.0015
353 CHOKING 30 0.0015
354 BLOOD PRESSURE DECREASED 102 0.0015
355 CIRCULATORY COLLAPSE 26 0.0015
356 THERAPY CHANGE 15 0.0015
357 GENERAL PHYSICAL HEALTH DETERIORATION 176 0.0015
358 WALKING AID USER 10 0.0015
359 COMA 72 0.0015
360 NEPHROGENIC ANAEMIA 7 0.0015
361 PULMONARY EMBOLISM 143 0.0015
362 LOWER GASTROINTESTINAL HAEMORRHAGE 11 0.0015
363 HAEMORRHOIDS 29 0.0015
364 JAUNDICE 40 0.0015
365 NEUROTOXICITY 26 0.0015
366 SPUTUM DISCOLOURED 14 0.0015
367 MUSCLE SPASTICITY 18 0.0015
368 BLOOD CREATINE PHOSPHOKINASE INCREASED 42 0.0015
369 ABASIA 36 0.0015
370 DECREASED APPETITE 333 0.0014
371 PANCREATITIS ACUTE 32 0.0014
372 STAPHYLOCOCCAL SEPSIS 7 0.0014
373 AORTIC VALVE INCOMPETENCE 6 0.0014
374 BODY HEIGHT DECREASED 15 0.0014
375 PRODUCT DISTRIBUTION ISSUE 13 0.0014
376 MICTURITION URGENCY 16 0.0014
377 AFFECTIVE DISORDER 11 0.0014
378 PLEURAL EFFUSION 85 0.0014
379 DYSLIPIDAEMIA 7 0.0014
380 PULMONARY THROMBOSIS 15 0.0014
381 BLOOD PRESSURE FLUCTUATION 33 0.0014
382 BLOOD UREA INCREASED 23 0.0014
383 SOMNAMBULISM 9 0.0014
384 FRUSTRATION TOLERANCE DECREASED 11 0.0014
385 CEREBRAL ISCHAEMIA 7 0.0014
386 HYPOTENSION 272 0.0014
387 BENIGN PROSTATIC HYPERPLASIA 7 0.0014
388 CEREBRAL DISORDER 10 0.0014
389 TARDIVE DYSKINESIA 38 0.0013
390 LEFT VENTRICULAR DYSFUNCTION 9 0.0013
391 CARDIAC PACEMAKER INSERTION 8 0.0013
392 THINKING ABNORMAL 25 0.0013
393 BRAIN FOG 21 0.0013
394 GASTROINTESTINAL INFECTION 12 0.0013
395 POSTOPERATIVE WOUND INFECTION 9 0.0013
396 ASTHENIA 501 0.0013
397 REBOUND EFFECT 15 0.0013
398 HERPES ZOSTER 76 0.0013
399 BODY TEMPERATURE DECREASED 13 0.0013
400 EATING DISORDER 28 0.0013
401 RIB FRACTURE 27 0.0013
402 HAEMODYNAMIC INSTABILITY 10 0.0013
403 HEART RATE DECREASED 46 0.0013
404 CATARACT 78 0.0013
405 PRODUCT SIZE ISSUE 7 0.0013
406 ENCEPHALITIS 9 0.0013
407 PRODUCTIVE COUGH 62 0.0013
408 FORMICATION 9 0.0013
409 FAECES DISCOLOURED 28 0.0013
410 INFUSION SITE EXTRAVASATION 8 0.0013
411 RECTAL HAEMORRHAGE 55 0.0013
412 HYPOKALAEMIA 59 0.0013
413 DERMATITIS ALLERGIC 16 0.0013
414 PRODUCT DOSE OMISSION ISSUE 372 0.0013
415 MUSCULAR WEAKNESS 143 0.0013
416 BLOOD PRESSURE ABNORMAL 25 0.0013
417 HYPOTHYROIDISM 40 0.0013
418 ACUTE KIDNEY INJURY 191 0.0012
419 CONSTIPATION 270 0.0012
420 DIZZINESS POSTURAL 12 0.0012
421 NOCTURIA 15 0.0012
422 CARDIAC FAILURE 99 0.0012
423 SCRATCH 13 0.0012
424 HAEMATURIA 42 0.0012
425 HAEMATEMESIS 31 0.0012
426 HEPATOMEGALY 12 0.0012
427 GLOMERULAR FILTRATION RATE DECREASED 15 0.0012
428 PRODUCT PRESCRIBING ERROR 29 0.0012
429 SKIN ATROPHY 7 0.0012
430 MOUTH SWELLING 7 0.0012
431 APPETITE DISORDER 8 0.0012
432 ANEURYSM 6 0.0012
433 HYDRONEPHROSIS 9 0.0012
434 PRODUCT ADMINISTRATION ERROR 24 0.0012
435 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 6 0.0012
436 IRRITABILITY 71 0.0012
437 BACTERAEMIA 14 0.0012
438 ACIDOSIS 9 0.0012
439 INSURANCE ISSUE 18 0.0012
440 MUSCLE TWITCHING 27 0.0012
441 VENTRICULAR FIBRILLATION 13 0.0012
442 INITIAL INSOMNIA 12 0.0012
443 ECCHYMOSIS 8 0.0012
444 SEPSIS 130 0.0012
445 ABNORMAL DREAMS 32 0.0012
446 HYPOALBUMINAEMIA 9 0.0012
447 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 60 0.0011
448 TENSION 7 0.0011
449 EXTRASYSTOLES 8 0.0011
450 HYPERTENSION 242 0.0011
451 DYSURIA 42 0.0011
452 CONCOMITANT DISEASE AGGRAVATED 7 0.0011
453 BLOOD POTASSIUM DECREASED 34 0.0011
454 PRODUCT DOSE OMISSION IN ERROR 32 0.0011
455 DRUG ERUPTION 20 0.0011
456 POLLAKIURIA 47 0.0011
457 JOINT INJURY 24 0.0011
458 INTENTIONAL DOSE OMISSION 32 0.0011
459 HAEMATOMA 29 0.0011
460 DEATH 958 0.0011
461 WOUND 31 0.0011
462 CHROMATURIA 25 0.0011
463 SHOCK HAEMORRHAGIC 9 0.0011
464 OXYGEN SATURATION DECREASED 62 0.0011
465 ASPHYXIA 9 0.0011
466 PERIPHERAL SWELLING 169 0.0011
467 WITHDRAWAL SYNDROME 46 0.0011
468 MAJOR DEPRESSION 8 0.0011
469 PNEUMONIA 353 0.0011
470 MOVEMENT DISORDER 35 0.0011
471 BRAIN NEOPLASM 10 0.0011
472 UROSEPSIS 10 0.0011
473 HEMIPLEGIA 9 0.0011
474 DRUG EFFECT LESS THAN EXPECTED 16 0.0011
475 ATRIAL FIBRILLATION 105 0.0011
476 POLYP 7 0.0011
477 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 76 0.0011
478 ORAL CANDIDIASIS 14 0.0011
479 ARTERIOSCLEROSIS 10 0.0011
480 DYSGRAPHIA 7 0.0011
481 RESPIRATORY DEPRESSION 13 0.0011
482 MITRAL VALVE INCOMPETENCE 12 0.0011
483 SARS-COV-2 TEST POSITIVE 14 0.0011
484 INADEQUATE ANALGESIA 9 0.0011
485 SPINAL OPERATION 13 0.0011
486 PETECHIAE 11 0.0011
487 PRODUCT AVAILABILITY ISSUE 24 0.0011
488 HYPERCALCAEMIA 13 0.0011
489 RESPIRATORY DISTRESS 29 0.0010
490 MELAENA 23 0.0010
491 FULL BLOOD COUNT ABNORMAL 11 0.0010
492 SUDDEN DEATH 11 0.0010
493 PRODUCT USE IN UNAPPROVED INDICATION 257 0.0010
494 HAEMOLYSIS 8 0.0010
495 MUSCULOSKELETAL STIFFNESS 90 0.0010
496 INFARCTION 7 0.0010
497 INSOMNIA 272 0.0010
498 CRYING 37 0.0010
499 MIDDLE INSOMNIA 19 0.0010
500 DEEP VEIN THROMBOSIS 66 0.0010
501 AMNESIA 66 0.0010
502 ANGINA PECTORIS 29 0.0010
503 ISCHAEMIC STROKE 18 0.0010
504 HAEMATOCRIT DECREASED 20 0.0010
505 BLOOD ALBUMIN DECREASED 8 0.0010
506 HAEMORRHAGE INTRACRANIAL 15 0.0010
507 THERAPEUTIC RESPONSE UNEXPECTED 45 0.0010
508 RIGHT VENTRICULAR FAILURE 7 0.0010
509 OEDEMA PERIPHERAL 121 0.0010
510 WHITE BLOOD CELL COUNT INCREASED 38 0.0010
511 HEPATOCELLULAR INJURY 14 0.0010
512 METASTASIS 7 0.0010
513 DIZZINESS 489 0.0010
514 NEUTROPHIL COUNT INCREASED 10 0.0010
515 METASTASES TO BONE 16 0.0010
516 BLOOD PRESSURE SYSTOLIC INCREASED 19 0.0010
517 STATUS EPILEPTICUS 11 0.0010
518 HAEMOGLOBIN DECREASED 100 0.0010
519 WEIGHT DECREASED 271 0.0010
520 ILEUS 12 0.0010
521 TOXICITY TO VARIOUS AGENTS 161 0.0010
522 MOOD ALTERED 26 0.0010
523 FACIAL PARALYSIS 8 0.0009
524 CHOLESTASIS 18 0.0009
525 SCAR 16 0.0009
526 INFUSION SITE PAIN 12 0.0009
527 DEPRESSED MOOD 49 0.0009
528 BLOOD ALKALINE PHOSPHATASE INCREASED 23 0.0009
529 OFF LABEL USE 809 0.0009
530 MACULAR DEGENERATION 11 0.0009
531 AGRANULOCYTOSIS 17 0.0009
532 DEVICE PHYSICAL PROPERTY ISSUE 7 0.0009
533 COMPLETED SUICIDE 76 0.0009
534 METASTASES TO LIVER 16 0.0009
535 LUNG INFILTRATION 8 0.0009
536 DISEASE PROGRESSION 107 0.0009
537 UNDERDOSE 66 0.0009
538 LUNG NEOPLASM MALIGNANT 37 0.0009
539 PELVIC FRACTURE 7 0.0009
540 FRACTURE 17 0.0009
541 LACTIC ACIDOSIS 29 0.0009
542 CARDIOMEGALY 11 0.0009
543 CYANOSIS 14 0.0009
544 HYPOGLYCAEMIA 43 0.0009
545 ASPARTATE AMINOTRANSFERASE INCREASED 47 0.0009
546 BODY TEMPERATURE INCREASED 18 0.0009
547 THERAPY INTERRUPTED 63 0.0009
548 TREATMENT FAILURE 73 0.0009
549 HYPERHIDROSIS 113 0.0009
550 INTERNAL HAEMORRHAGE 10 0.0009
551 DEVICE DISLOCATION 38 0.0009
552 OBSESSIVE-COMPULSIVE DISORDER 7 0.0009
553 DRUG INTOLERANCE 84 0.0009
554 MYASTHENIA GRAVIS 7 0.0009
555 KIDNEY INFECTION 17 0.0009
556 METASTASES TO LUNG 10 0.0009
557 SLEEP DISORDER 61 0.0009
558 GASTROINTESTINAL HAEMORRHAGE 72 0.0009
559 GAMMA-GLUTAMYLTRANSFERASE INCREASED 19 0.0009
560 HYPERKALAEMIA 30 0.0009
561 FATIGUE 665 0.0009
562 HYPOXIA 30 0.0009
563 PHOTOPHOBIA 16 0.0008
564 RESPIRATORY TRACT INFECTION 22 0.0008
565 BLOOD URINE PRESENT 16 0.0008
566 TREATMENT NONCOMPLIANCE 46 0.0008
567 RESPIRATORY DISORDER 25 0.0008
568 BLINDNESS 34 0.0008
569 RESPIRATORY ARREST 23 0.0008
570 ACUTE RESPIRATORY FAILURE 16 0.0008
571 AFFECT LABILITY 8 0.0008
572 GLAUCOMA 16 0.0008
573 HYPERCHOLESTEROLAEMIA 8 0.0008
574 BACK INJURY 9 0.0008
575 MENTAL DISORDER 36 0.0008
576 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 14 0.0008
577 RENAL IMPAIRMENT 69 0.0008
578 COVID-19 144 0.0008
579 FOOT DEFORMITY 9 0.0008
580 CARDIAC MURMUR 7 0.0008
581 HEPATOTOXICITY 18 0.0008
582 PYELONEPHRITIS 7 0.0008
583 IMPAIRED GASTRIC EMPTYING 11 0.0008
584 VERTIGO 49 0.0008
585 HEPATIC FUNCTION ABNORMAL 30 0.0008
586 PERIPHERAL COLDNESS 11 0.0008
587 DEPRESSION 181 0.0008
588 RESPIRATORY FAILURE 58 0.0008
589 RHINORRHOEA 51 0.0008
590 MUSCULOSKELETAL DISORDER 15 0.0008
591 CEREBROVASCULAR ACCIDENT 133 0.0008
592 BOWEL MOVEMENT IRREGULARITY 6 0.0008
593 HAEMARTHROSIS 7 0.0008
594 WEIGHT INCREASED 174 0.0008
595 PRESCRIBED OVERDOSE 15 0.0008
596 APNOEA 6 0.0008
597 DYSPNOEA EXERTIONAL 29 0.0008
598 BASAL CELL CARCINOMA 12 0.0008
599 NERVOUSNESS 40 0.0008
600 AGEUSIA 19 0.0008
601 THROMBOCYTOPENIA 85 0.0008
602 THERAPEUTIC PRODUCT EFFECT DECREASED 34 0.0008
603 BLOOD PRESSURE INCREASED 116 0.0008
604 PULMONARY CONGESTION 10 0.0008
605 SEPTIC SHOCK 33 0.0008
606 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 13 0.0008
607 INTERVERTEBRAL DISC DEGENERATION 7 0.0008
608 OEDEMA 41 0.0008
609 UPPER LIMB FRACTURE 15 0.0008
610 METABOLIC ACIDOSIS 24 0.0007
611 HEPATIC ENCEPHALOPATHY 7 0.0007
612 ALANINE AMINOTRANSFERASE INCREASED 46 0.0007
613 MALIGNANT MELANOMA 10 0.0007
614 CARDIO-RESPIRATORY ARREST 31 0.0007
615 HYPERGLYCAEMIA 27 0.0007
616 COLITIS 28 0.0007
617 BACK DISORDER 12 0.0007
618 SWELLING FACE 48 0.0007
619 SKIN ULCER 19 0.0007
620 ADVERSE DRUG REACTION 66 0.0007
621 LIVER INJURY 18 0.0007
622 PROSTATIC SPECIFIC ANTIGEN INCREASED 10 0.0007
623 THROMBOSIS 58 0.0007
624 BLOOD CREATININE INCREASED 47 0.0007
625 ARRHYTHMIA 34 0.0007
626 DERMATITIS 15 0.0007
627 DRY MOUTH 58 0.0007
628 EYE PRURITUS 24 0.0007
629 PRODUCT USE ISSUE 134 0.0007
630 BLOOD TEST ABNORMAL 10 0.0007
631 INFUSION RELATED REACTION 47 0.0007
632 VOMITING 333 0.0007
633 LIGAMENT SPRAIN 7 0.0007
634 SEASONAL ALLERGY 10 0.0007
635 MULTIPLE ORGAN DYSFUNCTION SYNDROME 20 0.0007
636 APPLICATION SITE PRURITUS 16 0.0007
637 BLADDER DISORDER 7 0.0007
638 DERMATITIS CONTACT 8 0.0007
639 THERAPY CESSATION 36 0.0007
640 RED BLOOD CELL COUNT DECREASED 20 0.0007
641 NEURALGIA 17 0.0007
642 EYE SWELLING 26 0.0007
643 PARALYSIS 10 0.0007
644 TACHYCARDIA 62 0.0007
645 NEPHROLITHIASIS 32 0.0007
646 OCULAR HYPERAEMIA 33 0.0007
647 HIATUS HERNIA 9 0.0007
648 DIPLOPIA 18 0.0007
649 INCORRECT PRODUCT ADMINISTRATION DURATION 15 0.0007
650 ULCER 11 0.0007
651 CYSTITIS 22 0.0007
652 CARDIAC ARREST 57 0.0007
653 COMPLICATION ASSOCIATED WITH DEVICE 10 0.0007
654 SUICIDAL IDEATION 63 0.0007
655 SENSORY DISTURBANCE 11 0.0007
656 EOSINOPHILIA 12 0.0007
657 SPINAL PAIN 8 0.0007
658 TEMPERATURE INTOLERANCE 7 0.0007
659 BLOOD POTASSIUM INCREASED 11 0.0007
660 SKIN HAEMORRHAGE 10 0.0007
661 BLOOD IRON DECREASED 8 0.0007
662 EYE DISCHARGE 7 0.0007
663 PULMONARY MASS 10 0.0007
664 MIGRAINE 64 0.0007
665 DRUG INEFFECTIVE 883 0.0007
666 TRANSFUSION 7 0.0007
667 WRIST FRACTURE 8 0.0007
668 JOINT DISLOCATION 7 0.0007
669 TACHYPNOEA 9 0.0007
670 ANXIETY 188 0.0007
671 ILLNESS 68 0.0007
672 END STAGE RENAL DISEASE 12 0.0007
673 EYE PAIN 37 0.0007
674 CENTRAL NERVOUS SYSTEM LESION 9 0.0007
675 DEAFNESS 17 0.0006
676 EMOTIONAL DISORDER 20 0.0006
677 BRONCHITIS 48 0.0006
678 CHEST PAIN 120 0.0006
679 CONVULSION 37 0.0006
680 FEELING COLD 18 0.0006
681 VISUAL IMPAIRMENT 80 0.0006
682 ANAEMIA 123 0.0006
683 MASS 9 0.0006
684 BIPOLAR DISORDER 7 0.0006
685 ILL-DEFINED DISORDER 39 0.0006
686 CARDIAC DISORDER 60 0.0006
687 DRUG ABUSE 53 0.0006
688 STAPHYLOCOCCAL INFECTION 21 0.0006
689 DIARRHOEA 410 0.0006
690 HYPOCALCAEMIA 12 0.0006
691 SINUS TACHYCARDIA 9 0.0006
692 THERAPEUTIC RESPONSE SHORTENED 21 0.0006
693 BACK PAIN 147 0.0006
694 GASTRIC ULCER 12 0.0006
695 PNEUMOTHORAX 10 0.0006
696 DYSPEPSIA 62 0.0006
697 FEELING JITTERY 12 0.0006
698 INFECTION 91 0.0006
699 PRODUCT DOSE OMISSION 41 0.0006
700 DERMATITIS ATOPIC 33 0.0006
701 EYE IRRITATION 36 0.0006
702 HOSPITALISATION 96 0.0006
703 RENAL DISORDER 29 0.0006
704 LYMPHOCYTE COUNT DECREASED 11 0.0006
705 IMPAIRED DRIVING ABILITY 7 0.0006
706 GOUT 11 0.0006
707 ANGIOEDEMA 27 0.0006
708 LIVER DISORDER 27 0.0006
709 PANCYTOPENIA 34 0.0006
710 CHILLS 71 0.0006
711 RESTLESS LEGS SYNDROME 11 0.0006
712 C-REACTIVE PROTEIN INCREASED 22 0.0006
713 HYPOACUSIS 26 0.0006
714 SKIN CANCER 13 0.0006
715 PULMONARY OEDEMA 27 0.0006
716 ELECTROLYTE IMBALANCE 7 0.0006
717 COUGH 168 0.0006
718 SPINAL FRACTURE 12 0.0006
719 QUALITY OF LIFE DECREASED 8 0.0006
720 LACRIMATION INCREASED 18 0.0006
721 HEART RATE INCREASED 59 0.0006
722 CHRONIC KIDNEY DISEASE 45 0.0006
723 TASTE DISORDER 12 0.0006
724 RENAL FAILURE ACUTE 25 0.0006
725 CHOLECYSTITIS 7 0.0006
726 THYROID DISORDER 9 0.0006
727 DIABETIC KETOACIDOSIS 14 0.0006
728 APPLICATION SITE RASH 8 0.0006
729 MUSCULOSKELETAL CHEST PAIN 9 0.0006
730 DRY EYE 29 0.0006
731 PYREXIA 201 0.0006
732 LUNG INFECTION 9 0.0006
733 LOCALISED INFECTION 14 0.0006
734 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 104 0.0006
735 MALAISE 252 0.0006
736 PULMONARY FIBROSIS 11 0.0006
737 NECK PAIN 32 0.0006
738 DRUG PRESCRIBING ERROR 11 0.0006
739 MOUTH ULCERATION 12 0.0006
740 DEVICE ISSUE 51 0.0006
741 COLD SWEAT 10 0.0006
742 BLINDNESS UNILATERAL 8 0.0006
743 BLOOD TRIGLYCERIDES INCREASED 10 0.0006
744 RETCHING 12 0.0006
745 UPPER RESPIRATORY TRACT INFECTION 26 0.0006
746 SECRETION DISCHARGE 7 0.0006
747 THROAT IRRITATION 25 0.0006
748 PRODUCT SUBSTITUTION ISSUE 32 0.0006
749 LIMB INJURY 15 0.0006
750 PRODUCT PRESCRIBING ISSUE 12 0.0006
751 RENAL FAILURE 73 0.0005
752 CLOSTRIDIUM DIFFICILE INFECTION 12 0.0005
753 CHOLELITHIASIS 18 0.0005
754 CARDIAC FAILURE CONGESTIVE 44 0.0005
755 HEPATITIS 14 0.0005
756 PRODUCT PHYSICAL ISSUE 11 0.0005
757 MULTIPLE SCLEROSIS 26 0.0005
758 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 110 0.0005
759 INJECTION SITE INDURATION 7 0.0005
760 TRANSAMINASES INCREASED 12 0.0005
761 NAUSEA 427 0.0005
762 ORAL PAIN 12 0.0005
763 HEADACHE 336 0.0005
764 SNEEZING 12 0.0005
765 PLATELET COUNT DECREASED 57 0.0005
766 FEELING ABNORMAL 128 0.0005
767 DYSPNOEA 302 0.0005
768 HEART RATE IRREGULAR 12 0.0005
769 OVERDOSE 114 0.0005
770 LOWER RESPIRATORY TRACT INFECTION 24 0.0005
771 MYOCARDIAL INFARCTION 92 0.0005
772 PROTEINURIA 10 0.0005
773 NEUROPATHY PERIPHERAL 50 0.0005
774 INTENTIONAL PRODUCT MISUSE 46 0.0005
775 SLEEP APNOEA SYNDROME 10 0.0005
776 MUSCLE SPASMS 96 0.0005
777 HERNIA 10 0.0005
778 RASH PRURITIC 28 0.0005
779 LIVER FUNCTION TEST INCREASED 11 0.0005
780 SUICIDE ATTEMPT 31 0.0005
781 CORONARY ARTERY OCCLUSION 7 0.0005
782 FUNGAL INFECTION 17 0.0005
783 ACUTE MYOCARDIAL INFARCTION 15 0.0005
784 DIVERTICULITIS 14 0.0005
785 PRODUCT DISPENSING ERROR 11 0.0005
786 ACTIVITIES OF DAILY LIVING IMPAIRED 10 0.0005
787 DISEASE RECURRENCE 24 0.0005
788 RESPIRATORY TRACT CONGESTION 8 0.0005
789 PREMATURE DELIVERY 8 0.0005
790 MOOD SWINGS 16 0.0005
791 SKIN DISCOLOURATION 23 0.0005
792 INTENTIONAL SELF-INJURY 10 0.0005
793 ABDOMINAL DISCOMFORT 83 0.0005
794 EPISTAXIS 37 0.0005
795 GASTRITIS 13 0.0005
796 MUSCLE TIGHTNESS 8 0.0005
797 CARDIOGENIC SHOCK 7 0.0005
798 VENTRICULAR TACHYCARDIA 8 0.0005
799 RASH 211 0.0005
800 MYELODYSPLASTIC SYNDROME 7 0.0005
801 ANOSMIA 7 0.0005
802 FEAR 13 0.0005
803 APPLICATION SITE IRRITATION 6 0.0005
804 FREQUENT BOWEL MOVEMENTS 13 0.0005
805 VIRAL INFECTION 16 0.0005
806 THROAT TIGHTNESS 13 0.0005
807 LEUKOPENIA 24 0.0005
808 WHITE BLOOD CELL COUNT DECREASED 52 0.0005
809 HEPATIC CIRRHOSIS 9 0.0005
810 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 14 0.0005
811 UNEVALUABLE EVENT 36 0.0005
812 UPPER GASTROINTESTINAL HAEMORRHAGE 8 0.0005
813 INFLUENZA 53 0.0005
814 ABDOMINAL PAIN LOWER 12 0.0005
815 FACE OEDEMA 8 0.0005
816 CARDIOMYOPATHY 7 0.0005
817 CHEST DISCOMFORT 48 0.0005
818 WRONG TECHNIQUE IN DRUG USAGE PROCESS 17 0.0005
819 HYPOAESTHESIA 70 0.0005
820 PANIC ATTACK 17 0.0005
821 BLISTER 26 0.0005
822 APPLICATION SITE ERYTHEMA 12 0.0005
823 DEVICE USE ISSUE 8 0.0005
824 HIP ARTHROPLASTY 7 0.0005
825 PAIN IN EXTREMITY 134 0.0005
826 INTESTINAL OBSTRUCTION 17 0.0005
827 NERVOUS SYSTEM DISORDER 14 0.0004
828 FULL BLOOD COUNT DECREASED 9 0.0004
829 DIABETES MELLITUS 34 0.0004
830 BONE MARROW FAILURE 9 0.0004
831 BLOOD LACTATE DEHYDROGENASE INCREASED 7 0.0004
832 PNEUMONITIS 12 0.0004
833 LABORATORY TEST ABNORMAL 13 0.0004
834 MALIGNANT NEOPLASM PROGRESSION 45 0.0004
835 HOT FLUSH 33 0.0004
836 MULTIPLE SCLEROSIS RELAPSE 30 0.0004
837 GASTRIC DISORDER 15 0.0004
838 ANAPHYLACTIC REACTION 24 0.0004
839 INTENTIONAL PRODUCT USE ISSUE 38 0.0004
840 HEPATIC STEATOSIS 8 0.0004
841 BLOOD CHOLESTEROL INCREASED 20 0.0004
842 KNEE ARTHROPLASTY 9 0.0004
843 DYSPHONIA 25 0.0004
844 MULTIPLE FRACTURES 7 0.0004
845 EYE DISORDER 14 0.0004
846 DRUG ADMINISTRATION ERROR 13 0.0004
847 RASH ERYTHEMATOUS 20 0.0004
848 HAEMATOCHEZIA 23 0.0004
849 POST PROCEDURAL COMPLICATION 8 0.0004
850 LOWER LIMB FRACTURE 8 0.0004
851 CANDIDA INFECTION 7 0.0004
852 ERUCTATION 8 0.0004
853 FLUSHING 42 0.0004
854 ABDOMINAL PAIN UPPER 85 0.0004
855 ASCITES 12 0.0004
856 STEVENS-JOHNSON SYNDROME 9 0.0004
857 WHEEZING 24 0.0004
858 NIGHT SWEATS 13 0.0004
859 SKIN EXFOLIATION 34 0.0004
860 RASH PAPULAR 9 0.0004
861 RASH MACULAR 14 0.0004
862 HEPATIC FAILURE 12 0.0004
863 HEPATIC ENZYME INCREASED 27 0.0004
864 IMPAIRED HEALING 13 0.0004
865 DIABETES MELLITUS INADEQUATE CONTROL 7 0.0004
866 HAEMOPTYSIS 11 0.0004
867 DISCOMFORT 24 0.0004
868 FLUID RETENTION 20 0.0004
869 ABDOMINAL DISTENSION 41 0.0004
870 VISUAL ACUITY REDUCED 13 0.0004
871 EXPIRED PRODUCT ADMINISTERED 13 0.0004
872 PRODUCT PREPARATION ERROR 8 0.0004
873 ANKLE FRACTURE 6 0.0004
874 PAIN 238 0.0004
875 VISION BLURRED 53 0.0004
876 TOOTH LOSS 8 0.0004
877 INCORRECT DOSE ADMINISTERED 88 0.0004
878 GASTROOESOPHAGEAL REFLUX DISEASE 31 0.0004
879 SWOLLEN TONGUE 12 0.0004
880 BLOOD GLUCOSE INCREASED 72 0.0004
881 GASTROINTESTINAL DISORDER 34 0.0004
882 PANCREATITIS 20 0.0004
883 ABSCESS 6 0.0004
884 PRURITUS 143 0.0004
885 FLATULENCE 21 0.0004
886 EXTRA DOSE ADMINISTERED 15 0.0004
887 BLOOD BILIRUBIN INCREASED 10 0.0004
888 FOOT FRACTURE 7 0.0004
889 NASOPHARYNGITIS 68 0.0004
890 INCREASED APPETITE 7 0.0004
891 SYSTEMIC LUPUS ERYTHEMATOSUS 13 0.0004
892 ABDOMINAL PAIN 85 0.0004
893 OSTEOPOROSIS 15 0.0004
894 SKIN LESION 10 0.0004
895 PRODUCT ADHESION ISSUE 13 0.0004
896 HAEMORRHAGE 38 0.0004
897 SWELLING 34 0.0004
898 MUSCULOSKELETAL PAIN 19 0.0004
899 LIP SWELLING 12 0.0004
900 RASH MACULO-PAPULAR 8 0.0004
901 ROAD TRAFFIC ACCIDENT 15 0.0004
902 SURGERY 21 0.0004
903 ADVERSE EVENT 33 0.0004
904 DRUG EFFECT INCOMPLETE 13 0.0004
905 NASAL CONGESTION 21 0.0004
906 GLYCOSYLATED HAEMOGLOBIN INCREASED 9 0.0004
907 TYPE 2 DIABETES MELLITUS 12 0.0004
908 LIMB DISCOMFORT 11 0.0004
909 SINUS DISORDER 7 0.0004
910 DRUG RESISTANCE 9 0.0004
911 DYSGEUSIA 26 0.0003
912 PARAESTHESIA 55 0.0003
913 TINNITUS 16 0.0003
914 SHOCK 8 0.0003
915 PERICARDIAL EFFUSION 8 0.0003
916 NEOPLASM MALIGNANT 23 0.0003
917 JOINT STIFFNESS 9 0.0003
918 INJURY 24 0.0003
919 MYALGIA 57 0.0003
920 PLASMA CELL MYELOMA 13 0.0003
921 BLOOD GLUCOSE DECREASED 16 0.0003
922 ARTHRITIS 26 0.0003
923 THERAPEUTIC RESPONSE DECREASED 20 0.0003
924 INFLAMMATION 17 0.0003
925 ARTHRALGIA 135 0.0003
926 HYPERSENSITIVITY 60 0.0003
927 SINUSITIS 33 0.0003
928 BACTERIAL INFECTION 6 0.0003
929 INTERVERTEBRAL DISC PROTRUSION 7 0.0003
930 NEOPLASM PROGRESSION 11 0.0003
931 CARDIOVASCULAR DISORDER 8 0.0003
932 INTENTIONAL OVERDOSE 20 0.0003
933 ERYTHEMA 64 0.0003
934 LYMPHADENOPATHY 11 0.0003
935 ASTHMA 35 0.0003
936 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 22 0.0003
937 PALPITATIONS 36 0.0003
938 INCORRECT DOSE ADMINISTERED BY DEVICE 8 0.0003
939 ANHEDONIA 8 0.0003
940 RENAL INJURY 9 0.0003
941 EAR INFECTION 8 0.0003
942 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 7 0.0003
943 DEVICE MALFUNCTION 21 0.0003
944 NEUTROPHIL COUNT DECREASED 12 0.0003
945 NEUTROPENIA 40 0.0003
946 FEELING HOT 18 0.0003
947 INFLUENZA LIKE ILLNESS 24 0.0003
948 FIBROMYALGIA 7 0.0003
949 LUNG DISORDER 14 0.0003
950 DRUG WITHDRAWAL SYNDROME 25 0.0003
951 JOINT SWELLING 34 0.0003
952 DEVICE LEAKAGE 12 0.0003
953 BONE PAIN 16 0.0003
954 RASH GENERALISED 7 0.0003
955 ALOPECIA 53 0.0003
956 MUCOSAL INFLAMMATION 7 0.0003
957 PROCEDURAL PAIN 7 0.0003
958 STOMATITIS 15 0.0002
959 DRY SKIN 33 0.0002
960 ACCIDENTAL EXPOSURE TO PRODUCT 25 0.0002
961 BURNING SENSATION 17 0.0002
962 OROPHARYNGEAL PAIN 22 0.0002
963 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 11 0.0002
964 ECZEMA 12 0.0002
965 URTICARIA 36 0.0002
966 DEVICE DIFFICULT TO USE 14 0.0002
967 NO ADVERSE EVENT 38 0.0002
968 INJECTION SITE BRUISING 16 0.0002
969 EMOTIONAL DISTRESS 24 0.0002
970 MYELOSUPPRESSION 7 0.0002
971 DRUG DOSE OMISSION 32 0.0002
972 OSTEOARTHRITIS 8 0.0002
973 PRODUCT QUALITY ISSUE 24 0.0002
974 SKIN IRRITATION 8 0.0002
975 DEVICE BREAKAGE 7 0.0002
976 FEBRILE NEUTROPENIA 11 0.0002
977 DRUG EFFECT DECREASED 8 0.0001
978 ARTHROPATHY 8 0.0001
979 PROSTATE CANCER 11 0.0001
980 MATERNAL EXPOSURE DURING PREGNANCY 12 0.0001
981 INJECTION SITE PRURITUS 9 0.0001
982 BREAST CANCER 12 0.0001
983 PRODUCT STORAGE ERROR 11 0.0001
984 BLADDER CANCER 7 0.0001
985 ACNE 9 0.0001
986 INJECTION SITE PAIN 35 0.0001
987 INJECTION SITE HAEMORRHAGE 9 0.0001
988 FOETAL EXPOSURE DURING PREGNANCY 9 0.0001
989 PSORIASIS 14 0.0001
990 INJECTION SITE ERYTHEMA 13 0.0001
991 DRUG DOSE OMISSION BY DEVICE 8 0.0001
992 INJECTION SITE SWELLING 7 0.0001
993 DRUG DEPENDENCE 14 0.0001
994 RHEUMATOID ARTHRITIS 7 0.0001